A wallet-first, non-custodial way to borrow against bitcoin, with clear loan terms and side-by-side comparisons, now including Morpho as a DeFi borrowing optionA wallet-first, non-custodial way to borrow against bitcoin, with clear loan terms and side-by-side comparisons, now including Morpho as a DeFi borrowing option

Sats Terminal Integrates Morpho Into Borrow, Expanding DeFi Borrowing Options for Bitcoin Holders

A wallet-first, non-custodial way to borrow against bitcoin, with clear loan terms and side-by-side comparisons, now including Morpho as a DeFi borrowing option.

San Francisco, USA, JANUARY 15, 2026 — Sats Terminal today announced the integration of Morpho into Borrow by Sats Terminal, adding Morpho as a new decentralized finance (DeFi) borrowing option within its bitcoin borrowing interface.

The integration allows users to access stablecoin liquidity using bitcoin as collateral through Morpho, directly from the Borrow interface. Users can review key loan details, including loan-to-value (LTV), interest rates, fees, collateral requirements, and liquidation parameters, before confirming from their wallet.

Sats Terminal remains non-custodial at the interface. Users sign transactions directly from their wallet, while borrowing activity is executed with the underlying protocol. Centralized and decentralized borrowing options are presented side by side, giving users a clearer view of trade-offs before committing.

Expanding DeFi borrowing on Borrow

Bitcoin-backed borrowing has historically been fragmented, with users navigating separate platforms, inconsistent terminology, and opaque terms. By integrating Morpho, Sats Terminal expands the set of DeFi borrowing options available within Borrow while maintaining a consistent, transparent user experience.

From a single interface, users can now:

  • compare DeFi borrowing options
  • review loan terms before signing
  • borrow without selling their bitcoin
  • remain in control of their keys throughout the process

The Morpho integration reflects how the market operates today, supporting bitcoin-native flows where possible and wrapped BTC where required, while making those mechanics explicit to the user.

How the Morpho integration works

When borrowing via Morpho on Sats Terminal, bitcoin is wrapped and bridged to EVM, where it is used as collateral on the Morpho protocol. Borrowed stablecoins are issued directly by Morpho and delivered to the user’s wallet.

All steps are handled through Borrow’s guided flow, so users do not need to manage bridging, protocol interactions, or smart contracts themselves.

Why Morpho

Launched in 2022, Morpho has quickly become one of the most widely used lending protocols in DeFi. At the time of writing, it leads DeFi lending by monthly active users, accounting for 44% of MAU share, and secures several billions of dollars in total value locked (TVL).

Morpho is designed to operate decentralized finance in the background while users interact through familiar, intuitive interfaces. As a result, millions of users access Morpho through large-scale integrations across the crypto ecosystem.

Recent milestones include:

  • #1 DeFi lending protocol by monthly active users (44% MAU share)
  • $1B+ in active loans via the Coinbase integration, with nearly $500M in USDC earning yield
  • User growth from 67,000 to 1.4M users in 2025 alone

By integrating Morpho into Borrow, Sats Terminal gives bitcoin holders access to a DeFi lending layer that is already proven at scale, while preserving a clear, wallet-first, non-custodial borrowing experience.

Comment from Sats Terminal

“Borrow by Sats Terminal is about making Bitcoin borrowing easier to understand and easier to compare”, said Stan Havryliuk, CEO and co-founder of Sats Terminal. “Integrating Morpho adds a strong DeFi option to Borrow and gives users another transparent way to access liquidity using their bitcoin, all without leaving the interface or giving up control of their keys.”

About Sats Terminal

Sats Terminal is a Bitcoin-native borrowing and trading platform that brings together centralized and decentralized liquidity through a single, wallet-first interface. Borrow by Sats Terminal allows users to compare BTC-backed borrowing options across multiple venues with clear visibility into terms before signing.

Sats Terminal is backed by YZi Labs, Coinbase Ventures, and Draper Associates.

Visit borrow.satsterminal.com

Disclaimer

This announcement is for informational purposes only and does not constitute financial, legal, or tax advice. Borrowing involves risk, including potential liquidation or loss of funds. Sats Terminal is non-custodial at the interface; underlying protocols may involve additional risks. Users are responsible for compliance with local regulations.

Comments
Market Opportunity
MORPHO Logo
MORPHO Price(MORPHO)
$1.3747
$1.3747$1.3747
-2.25%
USD
MORPHO (MORPHO) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26